Asia Pacific Oxygen Therapy Market

Asia Pacific Oxygen Therapy Market Size, Status and Forecast 2021
Asia Pacific Oxygen Therapy Devices Market was worth USD 0.34 billion in 2016 and
estimated to be growing at a CAGR of 7.92%, to reach USD 0.49 billion by 2021. Oxygen
therapy involves administering oxygen through an external device.
Oxygen Therapy devices are useful specially for people suffering from severe COPD or
cystic fibrosis who suffer from chronically low oxygen levels in their body. Advantages of
oxygen therapy also include increased mental stamina, aversion of heart failure, and an
enhanced breathing pattern. The administration and supply of supplementary oxygen have
turned into an indispensable part in the management of numerous diseases. Furthermore,
oxygen therapy is applicable to numerous diseases, for example, asthma, respiratory
distress syndrome, and obstructive sleep apnoea. Long-term oxygen treatments in patients
suffering from chronic lung disease are believed to enhance the length and the quality of
life.
View Full Report: http://marketdataforecast.com/market-reports/asia-pacificoxygen-therapy-market-3691/
The growth of the Asia-Pacific oxygen therapy market is mainly driven by the rise in
different respiratory diseases and the increasing awareness among general population
regarding personal health. The Asia-Pacific region is expected to offer a lucrative market in
the future due to the increasing elderly population who require home-based oxygen
therapy. Furthermore, increasing application of oxygen supply is expected to further boost
the growth of the market. Be that as it may, poor compensation and constantly changing
regulations related to oxygen therapy devices are expected to hamper the growth of the
Asia-Pacific oxygen therapy devices market in near future. Despite the fact that the AsiaPacific oxygen therapy devices market is expecting hindrances due to a couple of
restrictions, it will discover new development opportunities in growing economies.
Furthermore, government's initiative towards improving respiratory care and an increase in
government funding for the introduction of new medical devices are predicted to profit the
Asia-pacific oxygen therapy devices market.
Request For Sample Brochure: http://marketdataforecast.com/marketreports/asia-pacific-oxygen-therapy-market-3691/request-sample
The Asia-Pacific oxygen therapy devices market is segmented into product type, application
and end user. On the basis of product, it is segmented into Oxygen Source Equipment,
Cylinders, Concentrators, Liquid Oxygen Devices, PAP, Oxygen Delivery Device, Masks,
Nasal Cannula, Venturi Mask, Non-Rebreather Mask, Bag Valve and CPAP. Oxygen source
equipment are expected to grow at 11% CAGR It is attributed to the consolidation of this
equipment in the extensive variety of uses as the first line of treatment. On the basis of
application, it is segmented into Chronic Obstructive Pulmonary Disease, Asthma,
Obstructive Sleep Apnoea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia.
Chronic obstructive pulmonary disease holds the largest share of the application segment
and it is anticipated to grow lucratively at a CAGR of over 10.5% over the next five years.
This is due to increasing popularity of supplemental administration in conjunction with first
line treatments available for COPD. Moreover, this treatment includes faster response rates,
reliability and portability, and above all improves chances of survival. On the basis of end
use it is segmented into Home Healthcare and Hospitals). Home health care dominates the
end-use segment, owing to the rise in elderly population coupled with increasing number of
patients with low mobility and long-term care requirement in conditions such as Alzheimer’s
disease.
Market Segmentation
Product
Introduction
Oxygen Source Equipment
Oxygen Concentrators
Fixed Oxygen Concentrators
Portable Oxygen Concentrators
Liquid Oxygen Devices
Oxygen Cylinders
Oxygen Delivery Devices
Oxygen Masks
Nasal Cannulas
Venturi Masks
Non-Rebreather Masks
Bag Valve Masks
Other Devices
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
Portability
Introduction
Stationary Oxygen Therapy Devices
Portable Oxygen Therapy Devices
Y-o-Y Growth Analysis, By Portability
Market Attractiveness Analysis, By Portability
Market Share Analysis, By Portability
Application
Introduction
Chronic Obstructive Pulmonary Disease
Asthma, Obstructive Sleep Apnea
Respiratory Distress Syndrome
Cystic Fibrosis
Pneumonia
End User
Introduction
Home Care Settings
Hospitals
Ambulatory Surgical Centers & Physician Offices
Others
Inquire BeforeBuying: http://marketdataforecast.com/market-reports/asiapacific-oxygen-therapy-market-3691/inquire
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea,
and Australia. Asia-Pacific is expected to be the most promising region for oxygen therapy
devices and is stated to witness exponential growth in the coming years. Factors such as
large elderly population, increasing economic growth, rapidly increasing awareness among
individuals regarding personal wellbeing, government based initiatives promoting oxygen
therapy devices and better health care facilities are the key reasons boosting the market in
developing countries such as India and China.
This market is extremely disjointed with numerous big and developing players operating in
the business. The major companies dominating the oxygen therapy devices market in this
region are Respironics Inc. (a Philips company), Teleflex Incorporated, AirSep Corporation,
DeVilbiss Healthcare, ResMed, Inc, Fisher & Paykel Healthcare Limited, Invacare
Corporation.
About Us:
Market Data Forecast is a firm working in the area of market research and business
intelligence. With rich experience in research across various business domains, we
cater to the needs of both individual and corporate clients. Our analyst team comprises
expert professionals in market research, who with their collective knowledge and
sksillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/pressreleases

Asia Pacific Oxygen Therapy Devices Market was worth USD 0.34 billion in 2016 and estimated to be growing at a CAGR of 7.92%, to reach USD 0.49 billion by 2021.